A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China

Study Overview
=================
Brief Summary
-----------------
Limb-girdle muscular dystrophies (LGMD) are a series of rare progressive genetic disorders that are characterized by wasting and weakness of the voluntary proximal muscles. The onset of the disease is usually at young age, and most patients will be wheelchair-bound due to the progressive deterioration. Since currently genetic therapies for this disease are still immature, better natural history and genotype-phenotype studies are needed for preparing future therapies.

Detailed Description
-----------------
This is multicentered-based, prospective, and observational study, which mainly focuses on the diagnosis and progression of limb-girdle muscular dystrophies (LGMD) in China. the investigators collect patient data including basic information, strength evaluations, genetic data, electromyography results, pathology imaging from muscle biopsies, and MRIs. Previously collected patient data may also be enrolled in this study.

Official Title
-----------------
A Multicenter Phenotype-Genotype Analysis of Limb Girdle Muscular Dystrophy Patients in China

Conditions
-----------------
LGMD, LGMDR2, LGMDR1

Intervention / Treatment
-----------------
* Diagnostic Test: Electromyography
* Diagnostic Test: IDEAL MRI


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Identified with variants regarding LGMD related genes revealed by genetic sequencing Progressive weakness involving shoulder girdle and/or pelvic girdle Myopathic changes in electromyography or in pathological studies Exclusion Criteria: Identified with variants in other genes (non-LGMD related) that may cause muscular dystrophies

Ages Eligible for Study
-----------------
Minimum Age: 10 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| LGMD patients<br> | Diagnostic Test: Electromyography<br>* Electromyography (EMG) would be used at the baseline for dignoisis and furtue analysis.<br>Diagnostic Test: IDEAL MRI<br>* Muscle-speciifc sequences (e.g. IDEAL) would be used to scan patients at baseline and follow-up stages to characterize the fat fraction and atrophy in different muscles.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in NSAA score | The North Star Ambulatory Assessment (NSAA) is a 17-item rating scale with a score range of 0-34. It is used to measure the functional motor abilities of ambulant patients with muscular dystrophy. A lower NSAA score indicates more severe damage to the participant's motor capability. | Baseline, Year 1, Year 3, Year 5 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in muscle fat infiltration | The muscle-specific fat fraction can be calculated with special MRI sequences such as IDEAL or Dixon in the region of interest. An deep-learning based tool is applied to segment individual muscles. | Baseline, Year 3, Year 5 | 
| Changes in 6 Minute Walk Test | The 6-Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered in 6 minutes serves as the outcome for comparing changes in performance capacity. | Baseline, Year 3, Year 5 | 
| Changes in 10 Metre Walk Test (10MWT) | The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function | Baseline, Year 3, Year 5 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Observational